Gene expression tests for women with early stage breast cancer a review of clinical utility and cost-effectiveness

While each gene expression test has been independently clinically validated using prospective or retrospective evidence, currently, there is no gold-standard for breast cancer gene expression tests. This highlights the need for comparative assessments of clinical utility and cost-effectiveness

Main Authors: Narain, Tasha, Adcock, Lorna (Author)
Corporate Author: Canadian Agency for Drugs and Technologies in Health
Format: eBook
Language:English
Published: Ottawa (ON) Canadian Agency for Drugs and Technologies in Health October 16, 2017, 2017
Edition:Version 1.0
Series:Rapid response report: summary with critical appraisal
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Summary:While each gene expression test has been independently clinically validated using prospective or retrospective evidence, currently, there is no gold-standard for breast cancer gene expression tests. This highlights the need for comparative assessments of clinical utility and cost-effectiveness
Physical Description:1 PDF file (14 pages) illustrations